A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT00096993 · COMPLETED

Trial details

NCT number: NCT00096993
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2005-01-01
Primary completion: 2007-09-01
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.